-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QGi6i7NWvlQBCMIWm7SRO3Xg/sETyi6omJhZ/8ogleYH7Uw8hwNGMd/WXnPeVnRw Xxn9RttigkLvY8HS/RrOWg== 0000946486-06-000054.txt : 20061219 0000946486-06-000054.hdr.sgml : 20061219 20061219155209 ACCESSION NUMBER: 0000946486-06-000054 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061215 FILED AS OF DATE: 20061219 DATE AS OF CHANGE: 20061219 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DISCOVERY LABORATORIES INC /DE/ CENTRAL INDEX KEY: 0000946486 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943171943 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2600 KELLY ROAD STREET 2: SUITE 100 CITY: WARRINGTON STATE: PA ZIP: 18976 BUSINESS PHONE: 2154889300 MAIL ADDRESS: STREET 1: 2600 KELLY ROAD STREET 2: SUITE 100 CITY: WARRINGTON STATE: PA ZIP: 18976 FORMER COMPANY: FORMER CONFORMED NAME: ANSAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 19961121 FORMER COMPANY: FORMER CONFORMED NAME: ANSAN INC DATE OF NAME CHANGE: 19950609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LOPEZ DAVID L CENTRAL INDEX KEY: 0001283889 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26422 FILM NUMBER: 061286537 BUSINESS ADDRESS: STREET 1: 350 S MAIN ST STREET 2: STE 307 CITY: DOYLESTOWN STATE: PA ZIP: 18901 BUSINESS PHONE: 2153404699X140 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2006-12-15 0 0000946486 DISCOVERY LABORATORIES INC /DE/ DSCO 0001283889 LOPEZ DAVID L 2600 KELLY ROAD WARRINGTON PA 18976 0 1 0 0 Executive VP & Legal Counsel Common Stock 2006-01-25 5 A 0 262 6.68 A 20453 D Common Stock 2006-03-31 5 A 0 256 7.33 A 20709 D Common Stock 2006-06-30 5 A 0 898 2.09 A 21607 D Common Stock 2006-09-30 5 A 0 1033 1.816 A 22640 D Non-Qualified Stock Option (right to buy) 2.46 2006-12-15 4 A 0 220000 0 A 2006-12-15 2016-12-15 Common Stock 220000 220000 D Transaction reported on Table I represents Issuer's matching stock contribution pursuant to 401(k) plan. This employee stock option shall vest 25% on the date of the grant, and the balance shall vest in a series of three successive equal annual installments beginning with the first year anniversary of the grant. David L. Lopez, Esquire 2006-12-19 -----END PRIVACY-ENHANCED MESSAGE-----